Top 20 atyrpharma.com competitors & alternatives
[Evolutionary Intelligence - aTyr Pharma aTyr is harnessing newly discovered pathways in biology to create first-in-class therapeutics.]
atyrpharma.com competitors and alternatives
Top 20 atyrpharma.com competitors and alternatives are ranked by similar search terms, traffic and worth.
atyrpharma.com's top 5 competitors are: cocrystalpharma.com with 235 daily traffic and 106,900 estimated worth, vir.bio with 0 daily traffic and 106,400 estimated worth, fatetherapeutics.com with 9,000 daily traffic and 68,900 estimated worth, archventure.com with 22,667 daily traffic and 45,200 estimated worth, meipharma.com with 100 daily traffic and 31,300 estimated worth.
vir.bio
Vir Biotechnology | Powering the Immune System to Transform Lives
Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Daily Traffic: 0
Website Worth: $ 106,400
fatetherapeutics.com
Home - Fate Therapeutics
Fate Therapeutics - Guiding Cells to Improve Life. Uniting our unmatched knowledge of stem cell biology with a relentless pursuit of new discoveries to develop therapeutics that modulate pathways of cell fate.
Daily Traffic: 9,000
Website Worth: $ 68,900
archventure.com
Home - ARCH Venture Partners
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Daily Traffic: 22,667
Website Worth: $ 45,200
albireopharma.com
Ipsen - improving patient health outcomes
Ipsen is a global biopharmaceutical company, improving patients’ lives through research and innovation in oncology, rare disease & neuroscience.
Daily Traffic: 35
Website Worth: $ 24,600
altapartners.com
Leading Healthcare Venture Capital Firm | Alta Partners
Alta Partners is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996.
Daily Traffic: 6,500
Website Worth: $ 22,600
fshsociety.org
Facioscapulohumeral Muscular Dystrophy Info - Treatment - FSHD Society
Get Involved in the fight to cure FSHD muscular dystrophy. Newly or recently diagnosed? Please contact us to - Volunteer - Join - Donate.
Daily Traffic: 0
Website Worth: $ 11,900
jain-foundation.org
Jain Foundation - Dysferlin Registry - LGMD2B/R2 - DYSFERLINOPATHY - MIYOSHI MYOPATHY 1
orchestrating a cure for dysferlinopathy
the jain foundation is singularly focused on finding a cure for dysferlinopathy, also referred to as lgmd2b, lgmdr2, miyoshi myopathy 1 learn more
orchestrating
a cure for
Daily Traffic: 0
Website Worth: $ 11,000
fshd-europe.info
FSHD Europe Official Website | Support and Resources for FSHD
Visit FSHD Europe to access comprehensive information, support networks, and resources for individuals affected by Facioscapulohumeral Muscular Dystrophy (FSHD) across Europe.
Daily Traffic: 0
Website Worth: $ 100
aptevotherapeutics.com
Aptevo Therapeutics | Clinical Stage Immuno-Oncology Company
Aptevo Therapeutics is a Seattle-based biotech company focused on advancing the science of what’s next in oncology and hematology
Daily Traffic: 0
Website Worth: $ 0
crinetics.com
Crinetics - Developing Therapies For Rare Endocrine Diseases
Crinetics is here for rare endocrine disease patients who are eager to find therapies that provide effective disease control and more simplicity in their lives.
Daily Traffic: 0
Website Worth: $ 0
essapharma.com
Welcome - ESSA Pharma
Aniten Compounds Current prostate cancer hormonal therapies work by either depleting levels of androgen, inhibiting the synthesis of androgens, or by preventing androgen from binding to the androgen receptor (AR). However, prolonged treatment to current therapies can render cancer resistant to existing therapies over time. ESSA has developed a new class of drugs called anitens
Daily Traffic: 0
Website Worth: $ 0
lgmd-info.org
Home | LGMD Awareness Foundation
ABOUT US
LGMD Awareness Foundation, Inc. is a 501(c)(3) non-profit advocacy organization dedicated to globally raising awareness of the rare neuromuscular conditions known as limb-girdle muscular dystrophy (LGMD). In collaboration with other LGMD foundations, our focus is to provide curated educational information and resources for the LGMD community and public.
By increasing
Daily Traffic: 0
Website Worth: $ 0
evokepharma.com
Evoke Pharma
MANAGEMENT
David A. Gonyer, R.Ph.
David A. Gonyer, R.Ph. is one of our co-founders and has served as our President and Chief Executive Officer and as a member of our board of directors since March 2007. From 2004 to 2007, Mr. Gonyer served as Vice President, Strategic and Product Development of
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like atyrpharma.com